Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular engineering of an EGFP/disintegrin-based integrin marker.

Diego Butera1, Roxane Maria Fontes Piazza, Mary Ann McLane

  • 1Laboratório de Imunopatologia, Instituto Butantan, Av. Vital Brasil, 1500, 05503-900 São Paulo, Brazil. dbutera@butantan.gov.br

Toxicon : Official Journal of the International Society on Toxinology
|June 1, 2005
PubMed
Summary

Researchers engineered a fluorescent protein (EGFP)-eristostatin fusion to track alphaIIbbeta3 integrin activity. This EGFP-eristostatin construct serves as a reliable biomarker in bioassays, aiding in the study of integrin function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data.

NPJ breast cancer·2026
Same author

Aberrant O-glycosylation genes and miR-21-5p targets define a molecular signature of tumor aggressiveness in triple-negative breast cancer.

Glycobiology·2026
Same author

RNA-DNA Fusomer Fibers With Customizable Physicochemical, Mechanical, and Biological Properties for Next-Generation Therapeutics.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Liquid-based genomic profiling in high-risk localized prostate cancer.

Frontiers in urology·2026
Same author

Multiple disulfide-bonded states confer extensive conformational diversity in fibrinogen.

Protein science : a publication of the Protein Society·2026
Same author

Ganglioside GM3 in the Tumor Microenvironment: Mechanisms of Signaling Regulation and Strategies for Angiogenesis Inhibition.

Biomolecules·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biotechnology

Background:

  • Disintegrins are peptides from viper venom that bind integrins with high affinity and selectivity.
  • Eristostatin (Er) specifically targets and inhibits the alphaIIbbeta3 integrin.

Purpose of the Study:

  • To engineer an enhanced green fluorescence protein (EGFP)-tagged eristostatin (EGFP-Er) as a biomarker for alphaIIbbeta3 integrin.
  • To validate the utility of EGFP-Er in bioassays utilizing fluorescence detection.

Main Methods:

  • Constructed a bacterial expression vector (pAZ) for EGFP fusion proteins.
  • Cloned the eristostatin gene into the pAZ vector to create EGFP-Er.
  • Expressed and purified EGFP-Er and EGFP using immobilized metal affinity chromatography (IMAC).

Related Experiment Videos

  • Characterized protein expression via SDS-PAGE and Western blot.
  • Assessed fluorescence and binding activity using confocal microscopy.

    • Main Results:

    • Successfully produced a 32 kDa EGFP-Er fusion protein.
    • Purified EGFP-Er and EGFP showed comparable fluorescence, indicating no loss of EGFP activity.
    • EGFP-Er selectively bound to immobilized platelets, confirming eristostatin's activity.
    • Confocal microscopy confirmed EGFP-Er's specific binding to alphaIIbbeta3 integrin.

    Conclusions:

    • The pAZ vector is suitable for expressing soluble EGFP-labeled proteins.
    • EGFP-fused disintegrins can serve as effective biomarkers for integrins.
    • Engineered EGFP-Er shows potential as a biomarker for alphaIIbbeta3 integrin in bioassays.